CEFTIZIM 2.5 G

CEFTIZIM 2.5 g is indicated for the treatment of clinical and subclinical mastitis in dairy animals.

Ceftizoxime, a beta-lactam cephalosporin antibiotic inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibit the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis.

Shake vial to loosen powder and then add 20 ml sterile water for Injection I.P. in the vial and immediately shake well vigorously till powder dissolves completely.

Use immediately after reconstitution.

The product is contraindicated in animals, which are known to have exhibited allergic reactions to cephalosporins.

The product has been developed for parenteral use in treatment of mastitis in dairy animals and has shown to be safe in that regard.

CEFTIZIM 2.5 g is to be administered by only Intravenous route after reconstitution at the dose rate of 5 mg/ kg body weight and repeat within 96 hours in severe clinical mastitis cases. CEFTIZIM 2.5 g injection is available along with sterile water for Injection I.P., disposable syringe and needle.